John J. Kirby
CIK 1556327 · Interim CFO · last filed 2025-12-30
John J. Kirby is an Interim CFO who has filed 23 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for VRCA, was dated Dec 30, 2025. Across all open-market trades the lifetime net is −$1.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $108.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$108.7K
4
23
-$1.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRCA | Interim CFO | 18,962 | $5.73 | $108.7K | $15.0K | 3 | 2025-12-30 |
| Aceragen, Inc. (ACGN) Delisted | CHIEF FINANCIAL OFFICER | — | $0.38 | — | $0 | 1 | 2023-02-02 |
| Aceragen, Inc. (IDRA) Delisted | CHIEF FINANCIAL OFFICER | 436,850 | $7.22 | $3.16M | -$16.5K | 15 | 2023-01-10 |
| VIROPHARMA INC (VPHM) Delisted | V.P., Chief Accounting Officer | — | — | — | $0 | 3 | 2013-06-12 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-30 | VRCA | Grant (A) | +10,000 | $0 | EDGAR |
| 2025-11-25 | VRCA | Buy (P) | +3,536 | $15.0K | EDGAR |
| 2024-11-06 | VRCA | Grant (A) | +54,267 | $0 | EDGAR |
| 2023-02-02 | Aceragen, Inc. (ACGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-10 | Aceragen, Inc. (IDRA) Delisted | Mixed | +279,261 | -$85.2K | EDGAR |
| 2022-07-07 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-26 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-21 | Aceragen, Inc. (IDRA) Delisted | Buy (P) | +10,000 | $6.2K | EDGAR |
| 2021-07-12 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |